Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Director's Dealing 2015

Aug 3, 2015

65830_rns_2015-08-03_975bafca-d48e-4bfb-90ef-7ec967b42584.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHARMAXIS LTD ABN 75 082 811 630

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Malcolm John McComas
Date of last notice 27 September 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Date of change 4 August 2015
No. of securities held prior to change Ordinary shares held indirectly: 343,793Options over ordinary shares: 40,000Ordinary shares held directly: Nil
Class Options over ordinary shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired Nil
Number disposed 20,000 options over ordinary shares (lapsed
upon expiry)
Value/Consideration Nil
Note: If consideration is non‐cash, provide details and estimated
valuation
No. of securities held after change Ordinary shares held indirectly: 343,793
Options over ordinary shares: 20,000
Ordinaryshares held directly: Nil
Nature of change Lapsing of employee options upon reaching
Example: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation in expiration date
buy‐back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non‐cash, provide details
and an estimated valuation
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change Part 3 –[+] Closed period Were the interests in the securities or contracts detailed above n/a traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to n/a proceed during this period? If prior written clearance was provided, on what date was this n/a provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3